Elanco Animal Health Inc

• Country

  United States of America

• Sector

  Health Care

• Industry group

  Pharmaceuticals, Biotechnology & Life Sciences

• Industry

  Pharmaceuticals

• Sub-sector

  Health Care

• Capitalization (millions of $)

  7074.1

• Ticker

  ELAN.K

• ISIN

  US28414H1032

• IPO date

  2018-09-20

• Availability on Russian exchanges

  Yes

• Reporting for

  2024-02-26

• Date fact. publication of reports

  2023-12-31

Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for pets and farm animals. The Company offers its products under four primary categories: Pet Health Disease Prevention, Pet Health Therapeutics, Farm Animal Future Protein & Health, and Farm Animal Ruminants & Swine. Pet Health Disease Prevention category provides portfolios of pet parasiticides in the pet health sector. Pet Health Therapeutics category offers a pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. It also provides treatments for otitis (ear infections), as well as cardiovascular and dermatology indications. Farm Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics. It also provides products in poultry and aquaculture production. Farm Animal Ruminants & Swine category consists of a range of farm animal products, including Rumensin and Baytril.